Ernexa Therapeutics (ERNAW) Current Leases (2010 - 2026)
Ernexa Therapeutics (ERNAW) reported Current Leases of $163000.0 for Q1 2026, down 23.47% on a YoY basis from $213000.0 in Q1 2025, and down 23.47% quarter-over-quarter from $213000.0 in Q4 2025.
Ernexa Therapeutics (ERNAW) Current Leases (2010 - 2026) Analysis & Trends
Ernexa Therapeutics has reported Current Leases for 17 years, with the latest figure at $163000.0 in Q1 2026.
- For the quarter ending Q1 2026, Current Leases fell 23.47% year-over-year to $163000.0; the trailing twelve-month figure through Mar 2026 stood at $163000.0 (down 23.47% YoY), and the FY2025 full-year result was $213000.0, up 2.9% from the prior year.
- Current Leases for Q1 2026 stood at $163000.0, down from $213000.0 in the prior quarter.
- The five-year high for Current Leases was $4.3 million in Q2 2024, with the low at $3000.0 in Q3 2022.
- Historically, Current Leases has averaged $770764.7 across 5 years, with a median of $213000.0 in 2025.
- Annual changes were most pronounced in 2022 — Current Leases sank 99.26% — and 2023, when it soared 38200.0%.
- Ernexa Therapeutics' Current Leases stood at $295000.0 in 2022, then jumped by 651.19% to $2.2 million in 2023, then sank by 90.66% to $207000.0 in 2024, then gained by 2.9% to $213000.0 in 2025, then fell by 23.47% to $163000.0 in 2026.
- The last three Current Leases figures came in at $163000.0 (Q1 2026), $213000.0 (Q4 2025), and $206000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 42,980.09 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Ernexa Therapeutics | - | - | - | 163,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 163,000.00 |
| Dec 31, 2025 | 213,000.00 |
| Sep 30, 2025 | 206,000.00 |
| Jun 30, 2025 | 217,000.00 |
| Mar 31, 2025 | 213,000.00 |
| Dec 31, 2024 | 207,000.00 |
| Sep 30, 2024 | 201,000.00 |
| Jun 30, 2024 | 4.27 Mn |
| Mar 31, 2024 | 2.87 Mn |
| Dec 31, 2023 | 2.22 Mn |
| Sep 30, 2023 | 1.15 Mn |
| Jun 30, 2023 | 173,000.00 |
| Mar 31, 2023 | 168,000.00 |
| Dec 31, 2022 | 295,000.00 |
| Sep 30, 2022 | 3,000.00 |
| Jun 30, 2022 | 390,000.00 |
| Mar 31, 2022 | 149,000.00 |
| Dec 31, 2021 | 426,000.00 |
| Sep 30, 2021 | 408,125.00 |
| Jun 30, 2021 | 383,923.00 |